181 related articles for article (PubMed ID: 21739481)
1. The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumors.
Surh I; Rundhaug JE; Pavone A; Mikulec C; Abel E; Simper M; Fischer SM
Mol Carcinog; 2012 Jul; 51(7):553-64. PubMed ID: 21739481
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
[TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice.
Kiraly AJ; Soliman E; Jenkins A; Van Dross RT
Prostaglandins Leukot Essent Fatty Acids; 2016 Jan; 104():44-53. PubMed ID: 26802941
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
Chen X; Jiang D; Wang J; Chen X; Xu X; Xi P; Fan Y; Zhang X; Guan Y
Int J Mol Med; 2015 Jan; 35(1):285-93. PubMed ID: 25352206
[TBL] [Abstract][Full Text] [Related]
5. The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin.
Simper MS; Rundhaug JE; Mikulec C; Bowen R; Shen J; Lu Y; Lin K; Surh I; Fischer SM
Mol Oncol; 2014 Dec; 8(8):1626-39. PubMed ID: 25034079
[TBL] [Abstract][Full Text] [Related]
6. The growth of malignant keratinocytes depends on signaling through the PGE(2) receptor EP1.
Thompson EJ; Gupta A; Vielhauer GA; Regan JW; Bowden GT
Neoplasia; 2001; 3(5):402-10. PubMed ID: 11687951
[TBL] [Abstract][Full Text] [Related]
7. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.
Muller-Decker K; Neufang G; Berger I; Neumann M; Marks F; Furstenberger G
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12483-8. PubMed ID: 12221288
[TBL] [Abstract][Full Text] [Related]
8. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
Rundhaug JE; Pavone A; Kim E; Fischer SM
Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
Han C; Wu T
J Biol Chem; 2005 Jun; 280(25):24053-63. PubMed ID: 15855163
[TBL] [Abstract][Full Text] [Related]
10. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
Meeran SM; Vaid M; Punathil T; Katiyar SK
Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
[TBL] [Abstract][Full Text] [Related]
11. A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.
Abrahao AC; Castilho RM; Squarize CH; Molinolo AA; dos Santos-Pinto D; Gutkind JS
Oral Oncol; 2010 Dec; 46(12):880-7. PubMed ID: 20951077
[TBL] [Abstract][Full Text] [Related]
12. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptor EP1 expression in vulvar cancer.
Buchholz A; Vattai A; Fürst S; Vilsmaier T; Zati Zehni A; Steger A; Kuhn C; Schmoeckel E; Dannecker C; Mahner S; Jeschke U; Heidegger HH
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5369-5376. PubMed ID: 36436093
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of tumor formation by topical administration of 15-deoxy-delta12,14-prostaglandin J2 in a model of skin carcinogenesis.
Millán O; Rico D; Peinado H; Zarich N; Stamatakis K; Pérez-Sala D; Rojas JM; Cano A; Boscá L
Carcinogenesis; 2006 Feb; 27(2):328-36. PubMed ID: 16113051
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.
Ni WJ; Tang LQ; Zhou H; Ding HH; Qiu YY
J Cell Mol Med; 2016 Aug; 20(8):1491-502. PubMed ID: 27098986
[TBL] [Abstract][Full Text] [Related]
16. IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.
Sharma SD; Meeran SM; Katiyar N; Tisdale GB; Yusuf N; Xu H; Elmets CA; Katiyar SK
Carcinogenesis; 2009 Nov; 30(11):1970-7. PubMed ID: 19759192
[TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells.
Sun B; Rong R; Jiang H; Zhang H; Wang Y; Bai X; Zhang M; Ma J; Xia S; Shu W; Zhang L; Leng J
Mol Cell Biochem; 2013 Jun; 378(1-2):195-203. PubMed ID: 23494562
[TBL] [Abstract][Full Text] [Related]
19. The EP1 subtype of prostaglandin E2 receptor: role in keratinocyte differentiation and expression in non-melanoma skin cancer.
Konger RL; Billings SD; Prall NC; Katona TM; Dasilva SC; Kennedy CR; Badve S; Perkins SM; Lacelle PT
Prostaglandins Leukot Essent Fatty Acids; 2009 Oct; 81(4):279-90. PubMed ID: 19625175
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
